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Abstract
The antisaccade task provides a laboratory analogue of situations in which
execution of the correct behavioural response requires the suppression of a more
prepotent or habitual response. Errors (failures to inhibit a reflexive prosaccade
towards a sudden onset target) are significantly increased in patients with
damage to the dorsolateral prefrontal cortex, and patients with schizophrenia.
Recent models of antisaccade performance suggest that errors are more likely to
occur when the intention to initiate an antisaccade is insufficiently activated within
working memory. Nicotine has been shown to enhance specific working memory
processes in healthy adults. We explored the effect of nicotine on antisaccade
performance in a large sample (N=44) of young adult smokers. Minimally
abstinent participants attended two test sessions and were asked to smoke one
of their own cigarettes between baseline and retest during one session only.
Nicotine reduced antisaccade errors and correct antisaccade latencies if
delivered before optimum performance levels are achieved, suggesting that
nicotine supports the activation of intentions in working memory during task
performance. The implications of this research for current theoretical accounts of
antisaccade performance, and for interpreting the increased rate of antisaccade
errors found in some psychiatric patient groups are discussed.
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Introduction
It is well established that administration of the cholinergic agonist nicotine results
in improvements in basic, or low-level psychomotor performance in humans. For
example, nicotine has been shown to increase finger tapping rate (West and
Jarvis 1986) and decrease reaction times (Bates et al 1994;Witte et al 1997,
Greisar et al 2002). Nicotine also improves performance on tests involving
sustained attention such as the Rapid Visual Information Processing task (e.g.
Warburton and Arnall 1994, Foulds et al 1996) and Continuous Performance test
(Levin et al 1998).
A number of studies have suggested that nicotine may additionally improve
performance on tasks that require high level cognitive control processes such as
error detection and correction, planning, updating working memory and active
response inhibition. For example, administration of nicotine can lead to better
performance on the n-back task (Ernst et al 2001, Kumari et al 2003) and random
letter generation (Mancuso et al 2001), both of which require monitoring and
updating information held in active or “working” memory.
The ability to inhibit the processing of irrelevant information and withhold
prepotent or habitual responses to external stimuli is a key function of working
memory (Roberts et al 1994). Nicotinic enhancement of inhibition of irrelevant or
conflicting material has been demonstrated using the Stroop test (Della Casa et
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al 1999) and the retrieval-induced forgetting paradigm (Edginton and Rusted
2003).  The antisaccade task (Hallet 1978) also provides a laboratory measure of
the ability to inhibit prepotent responses. The sudden appearance of an object in
the visual periphery typically captures attention, and elicits a “reflexive”
prosaccade in its direction (Findlay and Walker 1999). In the antisaccade task
participants are required to inhibit the prosaccade towards the target and instead
initiate a voluntary eye-movement (an antisaccade) to the opposite hemifield. As
a tool with which to study the effects of nicotine on cognitive function, the
antisaccade task has a number of advantages over neuropsychological
measures of inhibition such as Stroop. The neural mechanisms underlying
saccadic control are comparatively well charted (e.g. Leigh & Kennard, 2004),
and the oculomotor system has a limited output, which can easily be measured
with a high degree of precision using modern oculographic recording equipment.
In addition, the prosaccade task (in which participants are asked to make a
saccade towards a target) provides a useful control condition.
Antisaccade errors are significantly increased in patients with damage limited to
the dorsolateral prefrontal cortex (DLPFC) but not frontal eye fields (FEF)
(Pierrot-Deseilligny 2003). Accordingly, increased antisaccade errors have been
taken as evidence of dysfunctional dorsolateral prefrontal cortex in a number of
clinical populations (see Munoz & Everling, 2004) most notably schizophrenia.
Importantly, antisaccade errors are also significantly increased in the first degree
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relatives of patients with schizophrenia, and as such are considered a potentially
important marker of genetic vulnerability to the disorder (Calkins et al 2004).
According to recent models of antisaccade performance (Massen, 2004; Munoz
& Everling, 2004; Reuter & Kathmann, 2004), the sudden appearance of the
peripheral target triggers a “race” between two separate saccade programs – a
exogenously driven prosaccade towards the target, and an internally generated
(endogenous) antisaccade to the opposite hemifield. If the antisaccade can be
programmed fast enough, it “wins” the race, and the prosaccade is cancelled.
Alternatively, if the prosaccade is programmed fast enough (or the computation
for the antisaccade is too slow) an erroneous prosaccade is made first, and the
correct antisaccade follows. Parallel programming of saccades has been
demonstrated in several other tasks (e.g. Godijn and Theeuwes, 2002) but is
worth noting that the extent to which correct and incorrect responses are always
programmed in parallel is unclear – on some antisaccade trials errors may be
compounded by one or more further saccades toward the target before being
corrected.
Within the framework outlined above error rates can be considered to be a
function of the levels of activity in the neural systems responsible for initiating the
two competing saccades – the higher the baseline activity or the faster the rate of
rise, the sooner the threshold required to trigger a saccade is reached. Thus,
Massen (2004) argues that any experimental manipulation that non-selectively
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influences activity in both systems (e.g. increases or decreases activity equally in
both) will not result in a change in error rate.  In contrast, a manipulation that
either selectively increases activity in the neural systems responsible for the
prosaccade, or decreases activity in the neural systems responsible for the
antisaccade, should result in increased errors. Similarly an experimental
manipulation that does the opposite (e.g. either decreases activity in the neural
systems responsible for the prosaccade or increases activity in the neural
systems responsible for the antisaccade) would be expected to result in a
decrease in antisaccade errors.
According to this model, if nicotine is acting simply to increase general arousal,
and this increase impacts equally on activity in the neural systems underlying
both the endogenous and exogenously driven processes, then the likelihood of
either reaching threshold before the other would be unchanged, and there would
be no change in antisaccade error rate. However, if the effects of nicotine are
greater on high level endogenous processes (such as the ability to adequately
maintain the intention to initiate an antisaccade within working memory) than on
lower level exogenously driven processes, then nicotine ought to result in a
decrease in errors (as increased activity in the neural system underlying the
endogenous antisaccade would increase the likelihood of it reaching threshold
before the exogenous prosaccade).
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Two studies have reported that nicotine decreases antisaccade errors in patients
with schizophrenia (Larrison-Faucher et al 2004, Depatie et al 2002). However,
schizophrenia is associated with increased rates of smoking and alpha 7 nicotinic
receptor abnormalities (de Leon & Diaz, 2005; Martin-Ruis et al, 2003). Findings
in healthy populations are less consistent (Larrison-Faucher et al 2004; Larrison
et al, 2004; Roos et al, 1995; Powell et al 2002). Both Depatie et al (2002) and
Powell et al (2002) used overnight abstinent smokers , so the reduction in
antisaccade errors they report could be due to a reversal of a withdrawal-induced
deficit in performance. The only study to use minimally abstinent smokers
delivered 4mg nicotine gum (Larrison et al 2004) to task naïve subjects
participating in two sessions.  They reported a trend towards fewer errors but no
effect on saccade latencies on single-task blocks of the antisaccade task.
However, Larrison et al (2004) did not address the confounding of practice
effects and novelty effects, and thus did not compare performance amongst
those administered nicotine during their first experimental session to those
receiving nicotine on the second session.
In this study we used a crossover design that allows an easy differentiation
between improvements resulting from practice and those resulting from
enhancement by nicotine. Nicotine was delivered through smoking, and the
volunteers were moderate smokers (10-20 cigarettes per day) who were
minimally (two hours) abstinent prior to testing.  As a delivery system for nicotine
in habitual users, smoking provides better opportunity for self-titrated ‘optimal’
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delivery than recently available systems such as nasal spray (Myers et al, 2004)
nicotine patch (Poltavski & Petros, 2005) and gum (Harris et al, 2004).  This
avoids negative side effects, such as nausea, and the experiential differences
associated with unfamiliar delivery systems, which can significantly change the
outcome (Dar & Frenk, 2004). The two hour deprivation procedure minimises the
likelihood of subjective experience of ‘withdrawal’ or ‘craving’ in moderate
smokers during the test session and thus militates against an interpretation of
any cognitive effects in terms of deprivation reinstatement (see Heishman et al,
1994; Heishman, 1998 for reviews and discussion).
Methods
Participants
Participants were recruited for two separate studies with identical inclusion
criteria. These were that participants should be aged between 18-35, smoke 10-
20 cigarettes a day, habitually smoke before lunchtime and have normal or
corrected to normal vision. Both studies were part of the first author’s DPhil
programme. The second study was identical to the first, but contained an
additional third testing session and participants performed another variant of the
AS task at baseline. We do not present this additional data here. Twenty
volunteers (7 male) took part in study 1, mean (s.d.) age 22.3 (4.06) years. These
participants scored 3.95 (1.61) on the Fagerström (1978) measure of nicotine
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dependence, had been smoking on average for 6.13 (3.63) years and were 183
(88.1) minutes abstinent at the start of the experiment. Twenty four volunteers (4
male) took part in study 2. These participants were aged 20.6 (1.93), scored 4.46
(1.91) on the Fagerström (1978) questionnaire, had been smoking for 5.38 (2.18)
years and were 149 (34.3) minutes abstinent at the start of the experiment. The
larger mean and standard deviation in the time-to-last cigarette data from study 1
is due to one participant choosing not to smoke in the morning before her second
session. Independent t-test showed no differences (p>0.1) between participants
in the two studies on the above demographics and smoking characteristics. The
fact that the majority of participants were female reflects the gender bias in the
undergraduate psychology populations. Research has demonstrated that acute
effects of nicotine are not significantly mediated by gender related issues (see
Perkins et al, 1999 for a review).  To increase experimental power data was
collapsed across both studies and the combined data is reported here. All
participants were volunteers from the existing pool of subjects at the University of
Sussex, gave informed consent at the start of the first session and were paid £10
(study 1) or £15 (study 2) or received Psychology course credits for their
participation. The University of Sussex School of Life Sciences Ethics Committee
gave approval for this experiment.
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Tests
Participants were seated approximately 70cm from a 21inch monitor and eye-
movements were recorded with an Eyelink II eye tracker (SR-Research, Ontario,
Canada). The antisaccade task required participants to fixate a small red circle
(subtending approximately 0.5 degs) in the centre of the screen. In order to
increase the potential for observing facilitatory effects of nicotine we manipulated
the length of the gap between the offset of the fixation stimulus and the onset of
the peripheral target. Previous research has demonstrated that antisaccade
errors are significantly increased when a 200msec gap is introduced compared to
the 0msec gap or “step” version of the antisaccade task that is traditionally used.
We therefore used a 200msec gap condition and also a 500msec gap condition
that results in similar error rates as the standard 0msec “step” version (Fischer
and Weber 1997), but does not require attention to be disengaged from the
fixation stimulus at the time of target onset. After a random interval between 1000
and 1500 msec the central fixation stimulus disappeared and, after a gap (200 or
500 msec), was replaced by a peripheral target (a red circle of the same
diameter). The peripheral target appeared at one of four possible locations, +/- 4
and 8 degrees from fixation.  Participants were instructed to look as quickly and
as accurately as possible to the mirror image location of the target. Two blocks of
72 trials were performed at each baseline and retest. Within each block an equal
number of trials had 200 and 500 msec gaps, and the target appeared at each
location an equal number of times. Target location and gap length were varied
pseudorandomly such that no gap length or target location was used more than
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three times in a row. A 800Hz tone sounded for 50 msec at exactly the same time
as the target appeared.
Procedure
All participants were tested on two separate sessions, separated by between 2
and 7 days. Participants were requested to abstain from smoking for at least two
hours prior to arrival, and compliance with this request was monitored with end-
tidal CO readings taken on arrival. Mean (s.d.) end-tidal CO measures of 10.1
(5.12) for session 1 and 8.09 (4.56) for session 2 were taken as compliance with
this request. Both experimental sessions involved a baseline test of two 72-trial
blocks , a short break and a retest of two further 72-trial blocks. In counter-
balanced sessions participants were either asked to smoke one of their own,
preferred brand of cigarettes during the break, or to abstain throughout. Thus, 22
of the participants smoked between baseline and retesting in their first session
and abstained during the second. The remaining 22 participants abstained during
the first session and smoked between baseline and retesting in the second
session.  During the first session an 8-trial practice block of the antisaccade task
was performed to ensure that all participants had understood the task
instructions.
Analysis
The performance measures were percentage errors, latency for correct
antisaccades and correct antisaccade gain (the ratio of correct saccade
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amplitude and target amplitude). At each baseline and retest in the two sessions
mean scores were calculated from the two 72-trial blocks combined. In order to
explore between session effects baseline data were entered into a mixed ANOVA
with session (session 1 vs. session 2), gap length (200msec or 500msec gap),
smoking order (smoked in session 1 vs. smoked in session 2) and study
(participation in study 1 or 2) entered as factors. Less than 6% of the cells in the
ANOVA on error data had 0% errors. In order to explore the effects of nicotine,
we calculated difference scores (retest minus baseline) and entered these into a
mixed ANOVA with nicotine (smoked vs. abstained), gap length, smoking order
and study entered as factors. Less than 4% of the cells in the ANOVA on error
data had 0% errors.
Results
There were no significant differences on any baseline measure between those
who took part in study 1 or study 2 (p>0.1 for all main effects). There was a trend
towards faster latencies for correct antisaccades (F(1,40) = 3.23, p=0.08) and
fewer  errors (F(1,40) = 2.93, p=0.09) at the 200msec gap length amongst those
who took part in study 2. These reflect practice effects due to the additional block
of antisaccade trials performed in experiment 2. There were no main effects of, or
interactions with study (p>0.1) for the difference scores.
Baseline data:
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Significant main effects of session revealed practice effects for percent errors
and correct antisaccade latencies.  Percentage errors : F(1,40) = 22.4, p<0.001
and latencies for correct antisaccades, F(1,40) = 43.1, p<0.001 were lower at the
baseline test in the second session compared to the baseline test in the first
session. Participants made more errors overall for the 200 msec gap trials
compared to the 500 msec gap trials F(1,40) = 9.76, p < 0.01) and were also
generally faster to initiate correct antisaccades for 500msec gap trials compared
to 200 msec gap trails (F(1,40) = 57.1, p < 0.01).  These main effects of session
and gap length were qualified by significant interactions between session and
gap length (see Figure 1). These revealed that the improvement in percentage
errors occurred only for the 200msec gap length (F(1,40) = 24.8, p=0.003) and
that the reduction in correct antisaccade latency between the sessions was
greater for the 500msec gap compared to the 200msec gap trials F(1,40) = 29.7,
p<0.001).
In the baseline data, prior to delivery of nicotine, a significant interaction between
session and smoking order for antisaccade errors revealed a greater reduction in
errors from the first to the second session amongst those who had smoked in
session 1 (F(1,40) = 5.94, p<0.02), see table 1. Paired t-tests confirmed that the
difference in error rates between session 1 and 2 is significant for those who
smoked in session 1 (t=4.56, df=21, p<0.001) and significant at a trend level for
those who smoked in session 2 (t=1.87, df=21, p=0.077). An independent t-test
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revealed that the apparent difference in session 1 error rates between the two
smoking order groups is not significant (p=0.36).
For correct antisaccade amplitude the main effect of session was not significant
(F(1,40) = 0.24, p = 0.63). However, a significant session by gap interaction
(F(1,40) = 4.37, p < 0.05) arose because correct antisaccade amplitudes are
more hypometric at the baseline of the second session for 200 msec gap trials,
but not 500 msec gap trials. This was further qualified by a significant 3-way
interaction between session, gap and the between subjects factor smoking order
(F(1,40) = 14.6, p < 0.01). This unexpected interaction reflects the fact that
amplitudes were reduced for both gap lengths at the second session compared
to the first for participants who smoked in session 2,  whereas participants who
smoked in session one showed a reduction in amplitude for 200 msec gap trials,
but an increase in amplitude for 500 msec gap trials.
Insert Table 1. here
Nicotine effects
Smoking significantly reduced the number of antisaccade errors made (F
(1,40) = 11.2, p < 0.01) and the latency with which correct antisaccades were
initiated (F(1,40) = 5.61, p < 0.05) compared to abstaining.  As is clear from
figure 2, these main effects of nicotine were qualified by significant nicotine by
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smoking order interactions (percent errors, F(1,40) = 9.6, p < 0.01; correct
antisaccade latencies F(1,40) = 5.78, =< 0.05).  The interaction for percent errors
reflects the fact that errors were reduced after nicotine if the cigarette was
smoked during the first session (t = -4.31, df = 21, p < 0.01) but not during the
second session (t = -0.31, df = 21, p = 0.76). The interaction between nicotine
and smoking order for correct antisaccade latencies occurred because for those
participants who smoked in session 1 smoking resulted in significantly greater
reduction in correct antisaccade latencies than abstaining (t = -4.32, df = 21, p <
0.01), whereas, for those participants who smoked in session 2, both smoking
and abstaining resulted in small reductions that were equivalent (t= -0.01, df =
21, p = 0.99).  A three way interaction between nicotine, gap length and smoking
order for antisaccade errors (F(1,40) = 5.2, p< 0.05) occurred because nicotine,
when smoked in session 1, reduced errors on trials with a 200 msec gap to a
greater extent than errors on trials with a 500 msec gap. Paired t-tests performed
on data from each smoking order group separately confirm that errors on
200msec (t=-4.3, df=21, p<0.001) and 500msec (t=-2.58, df=21, p< 0.02) gap
trials are reduced after nicotine amongst those who smoked in session 1, while
there is no reduction in errors after nicotine at either gap length for those who
smoked in session 2 (p’s>0.1).
There was very weak overall effect of nicotine on correct saccade amplitude
(F.(1,40) = 3.06, p = 0.09) with nicotine generally resulting in a slight increase in
amplitude whereas abstinence resulted in a slight decrease. As with error rate
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and correct antisaccade latency, the nicotine by smoking order interaction was
significant (F(1,40) = 7.07, p < 0.01). However, unlike the equivalent interactions
for error rate and correct antisaccade latency, nicotine increased correct saccade
amplitude only if smoked in session 2. This interaction is not readily interpretable
and suggests that the trend for an overall effect of nicotine should be treated with
caution. The nicotine by gap interaction was also significant (F(1,40 = 11.7, p <
0.01). The interaction occurs because correct antisaccade amplitude is not
affected by nicotine or abstinence for 200 msec gap trials whereas nicotine
increases amplitudes and abstinence decreases amplitudes for 500 msec gap
trails.  In general, the effects of nicotine on correct antisaccade amplitude are
complex, and are difficult to interpret in the light of the baseline differences that
were observed.
Discussion
We investigated the effect of nicotine (administered in the form of a single
preferred brand cigarette) on antisaccade performance in a non-clinical
population. We found that nicotine led to a significant reduction in antisaccade
errors when it was received during the first experimental session. Nicotine also
led to a reduction in the latencies of correct antisaccades, and again, the
reduction was greater for participants who smoked in the first session. These
findings support previous work showing a nicotine-induced reduction in
antisaccade errors (Depatie et al 2002; Powell et al 2002; Larrison et al 2004)
and latencies (Larrison et al 2004) in healthy young adults. Further evidence for
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cholinergic modulation of antisaccade performance comes from reports of an
increase in antisaccade errors amongst schizophrenic patients administered the
cholinergic antagonist procyclidine (Ettinger et al 2003a).
A number of studies using similar designs have observed effects of nicotine only
when administered in the first session. Powell et al (2002) reported fewer
antisaccade errors after smoking in smokers permitted to smoke prior to the first
testing session but not those who smoked in the second session. Also, using a
complex visual search task, we found that nicotine reduced the number of
fixations and refixations of stimuli made during the search only if the cigarette
was smoked in the first session (Rycroft et al, 2005).
We found significant between sessions practice effects – average baseline error
rates were 20.1%  in the first session compared to 14.5% in the second session.
Other researchers have also demonstrated significant between sessions practice
effects for the antisaccade task (e.g. Ettinger et al, 2003b). One explanation of
our findings, and those described above, is that any facilitatory effects of nicotine
are more likely to be observed when performance is least optimal - as practice
improves performance towards the higher end of the range of possible scores,
ceiling effects reduce the potential for nicotine to induce any further
improvements. Our finding that nicotine led to a greater reduction in errors for the
200msec gap compared to the 500msec gap trials supports this interpretation –
baseline errors were higher for the 200msec compared to 500msec trials. This
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interpretation also clarifies the failure to observe facilitatory effects of nicotine on
antisaccade performance in a subgroup of schizophrenic patients who did not
have abnormally increased antisaccade errors (Larrison-Faucher, 2004, and the
fact that, in general, facilitatory effects of nicotine on antisaccade performance
have been more consistently observed in patients with schizophrenia (who have
high baseline levels of antisaccade errors) compared to healthy controls (Roos et
al 1995; Depatie et al 2002). This interpretation is also consistent with the finding
that participants with poor antisaccade performance benefit most from practice
effects (Ettinger et al 2003b).
If nicotine were acting to increase levels of arousal, one potential consequence
would be faster processing of the target – in which case (according to the model
of antisaccade performance outlined in the introduction) an increase in error rates
would be predicted. Alternatively, if a general increase in arousal led to faster
processing of the visual stimulus and faster programming of the correct
response, then no change in error rates would be expected. Our results support
the suggestion that nicotine has a facilitatory effect on endogenous, but not
exogenous, processes during antisaccade performance. In other words, nicotine
may be increasing activity in the neural systems responsible for initiating the
correct antisaccade response (Nieuwenhuis et al, 2004; Munoz & Everling, 2004)
over and above any influence they have on activity in the neural systems
responsible for target detection.
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Several converging lines of evidence confirm that working memory processes are
important moderators of antisaccade performance. Secondary tasks that place
demands on working memory capacity increase antisaccade errors while tasks
with the same motor or stimulus processing requirements (but no working
memory requirements) do not (Stuyven et al, 2000; Mitchell et al, 2002; Roberts
et al, 1994). Individuals with low working memory spans have slower latencies for
correct antisaccades and more antisaccade errors than individuals with high
working memory spans (Unsworth et al, 2004). Several studies have
demonstrated increased antisaccade errors in populations with known working
memory limitations. For example antisaccade errors and correct antisaccade
latencies are increased in patients with schizophrenia (Hutton et al, 1998; 2002),
and the degree of impairment correlates significantly with working memory
dysfunction in these patients (Hutton et al, 2004).  Similarly, increased
antisaccade errors reported in healthy elderly participants (e.g. Eenshuistra et al,
2004, Nieuwenhuis et al, 2004) have been attributed to lower activation of task
goals within working memory.
In the context of these findings, our results are consistent with current models of
antisaccade performance, and suggest that nicotine increases the extent to
which healthy participants are able to maintain the intention to initiate an
antisaccade within working memory. This results in a reduction in the time taken
to program a correct antisaccade, and consequently a reduction in the number of
trials in which an erroneous prosaccade is programmed first.  It is worth noting
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that another study exploring pharmacological manipulation of antisaccade
performance found results that are difficult to interpret within the general model of
antisaccade performance outlined in the introduction. Khan et  al (2003)
administered ethanol to healthy participants and found that it increased correct
antisaccade latency, but reduced the number of errors. Activation models would
predict that if the correct response is slowed, the erroneous response has a
greater likelihood of reaching threshold first, and therefore errors should
increase. The authors argued that the reduction in errors occurred because
ethanol slowed down the processing of the target. Activation models would still
be able to account for this pattern of results if the effect of ethanol was to slow
the processing of the peripheral stimuli to a greater extent that it slowed the
generation of the correct response. Further research using variants of pro and
antisaccade tasks and different pharmacological agents will provide important
insights into the interactions between stimulus and goal based behaviour.
In addition to a reduction in antisaccade errors and correct antisaccade latencies
we also found a novel “carryover” effect of nicotine on antisaccade error rate –
the improvement in baseline performance the first to the second session was
superior in those participants who had received nicotine in the first session
compared to those who had abstained. In other words those participants who
benefited maximally from nicotine by receiving it in the first session maintained
the improvements gained in that session for a period of a week. A similar effect in
monkeys was reported by Buccafusco et al (1995) following administration of
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nicotine or ABT-418, a centrally acting nicotinic cholinergic agonist. Both
compounds improved performance on the delayed-matching to sample task 10
minutes post-administration but only those given nicotine showed better
performance 24 hours later as well. Indeed, it has recently been suggested that
such long term effects of nicotine may reflect its action on cellular mechanisms
underlying learning and memory such as LTP (Buccafusco et al, 2005). These
findings suggest that acute effects of nicotine on cognitive function may have
consequences that last significantly longer than the pharmacokinetic properties of
the compound.
The pharmacological effects of nicotine are extremely complex. As well as
modulating the release of as a variety of different neurotransmitters such as
acetylcholine (Moore-Arnold et al 2003), glutamate (Vidal & Changeux, 1993),
dopamine (Corrigall et al 1994), serotonin (Reuben & Clarke 2000) and
noradrenalin (Clarke & Reuben 1996), there are a number of different  receptor
subtypes with different affinities for nicotine binding (Paterson and Nordberg
2000).  Since these have different thresholds for nicotine effects, behavioural
consequences of selective modulation of these subtypes are likely to be dose-
dependent (Kumari & Postma, 2005).  Both of the major subtypes of nicotinic
receptors, alpha-4 and alpha-7, reliably influence memory and attention
(Nordberg, 2001; Levin et el, 2006), but receptor subtype selectivity for specific
cognitive processes has been difficult to establish.  Both selective alpha-4 (Levin
& Christopher, 2002) and selective alpha-7 (Bettany and Levin 2001) compounds
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have been shown to modulate working memory performance in rat models, for
example. Previously, alpha-7 receptors particularly have been linked to lower
level processes - auditory gating, prepulse inhibition, priming (Freedman et al,
1994; Leonard et al, 1998)).  Whether goal activation in working memory is
mediated by effects on early perceptual processes or more direct prefrontal
activation is a focus for further research.
In summary, this study found that nicotine reduces the number of antisaccade
errors and increases the speed with which correct responses can be made. One
interpretation of these findings is that nicotine increases the strength of activation
in the memory representations supporting the goal to make antisaccades. As all
participants were minimally abstinent and allowed to maintain a relatively
naturalistic smoking pattern prior to the experiment the effects of nicotine are
unlikely to be due to a reversal of a withdrawal-induced deficit in performance.  In
addition, we have shown that the performance benefits derived from a single
acute dose of nicotine persist over a period of at least a week, possibly reflecting
the potential for nicotine to influence long term learning processes.
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Tables
Smoked in session 1 Smoked in session 2
Session 1 Session 2 Session 1 Session 2
% errors 22.00 (3.05) 13.46 (2.85) 18.23 (3.05) 15.49 (2.85)
Table 1. Mean (s.e.) percentage errors for both smoking order groups’ baseline
tests.
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Figure Legends
Fig. 1. Percentage errors (1a) and latencies for correct antisaccades  (1b) at the
baseline tests for both gap lengths.
Fig 2. Change in percentage errors (a) and antisaccade latency (b) after smoking
and abstinence for both smoking order groups.
